Table 2.
Odds Ratios of Incident Stroke Associated with Quartiles of HMW Adiponectin
| HMW Adiponectin Quartiles, μg/ml | # cases (%) | Model 1 † |
Model 2 ‡ |
||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | p-trend | OR | 95% CI | p-trend | ||
| < 5.2 (reference) | 213/427 (49.9%) | 1.00 | -- | 1.00 | -- | ||
| 5.2 – 11.0 | 218/432 (50.5%) | 1.02 | (0.78, 1.35) | 0.99 | (0.71, 1.37) | ||
| 11.1 – 18.8 | 220/434 (50.7%) | 1.03 | (0.78, 1.37) | 1.37 | (0.99, 1.91) | ||
| > 18.8 | 204/417 (48.9%) | 0.96 | (0.71, 1.29) | 1.25 | (0.88, 1.79) | ||
| 0.71 | 0.14 | ||||||
†
Crude (conditional on matching factors - age and race/ethnicity)
‡
Model 1 + BMI groups, type 2 diabetes, smoking, hypertension, LDL-C, HDL-C, METs, CRP and aspirin use